Christoffer Rosén

3.4k total citations · 1 hit paper
14 papers, 2.4k citations indexed

About

Christoffer Rosén is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Christoffer Rosén has authored 14 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Christoffer Rosén's work include Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (8 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Christoffer Rosén is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (8 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Christoffer Rosén collaborates with scholars based in Sweden, United Kingdom and United States. Christoffer Rosén's co-authors include Henrik Zetterberg, Kaj Blennow, Ulf Andréasson, Maria Bjerke, Ronald Lautner, Caroline Olsson, Bob Olsson, Erik Portelius, Max Petzold and Elizabeth Wu and has published in prestigious journals such as Brain, Neurology and The Lancet Neurology.

In The Last Decade

Christoffer Rosén

14 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

2016 1.4k citations Bob Olsson, Ronald Lautner et al. The Lancet Neurology profile →

Peers

Christoffer Rosén

PHYSI

PMH

MB

NEURO

Erik Stoops Belgium

Juan Lantero‐Rodriguez Sweden

Abdul Hye United Kingdom

Daniel Alcolea Spain

Kina Höglund Sweden

Audrey Gabelle France

Henrik Zetterberg Sweden

Mikko Hölttä Sweden

Inge M.W. Verberk Netherlands

Ronald Lautner Sweden

Erik Stoops Belgium

Christoffer Rosén

1.5k ×1.1

PHYSI

1.1k ×1.1

PMH

564 ×0.8

MB

518 ×1.1

NEURO

625 ×1.4

NEURO

Citations per year, relative to Christoffer Rosén Christoffer Rosén (= 1×) peers Erik Stoops

Countries citing papers authored by Christoffer Rosén

Since Specialization

Citations

This map shows the geographic impact of Christoffer Rosén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoffer Rosén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoffer Rosén more than expected).

Fields of papers citing papers by Christoffer Rosén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoffer Rosén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoffer Rosén. The network helps show where Christoffer Rosén may publish in the future.

Co-authorship network of co-authors of Christoffer Rosén

This figure shows the co-authorship network connecting the top 25 collaborators of Christoffer Rosén. A scholar is included among the top collaborators of Christoffer Rosén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoffer Rosén. Christoffer Rosén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Rosén, Christoffer, Bengt Nellgård, Markus Axelsson, et al.. (2024). High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS. Journal of the Neurological Sciences. 463. 123112–123112. 8 indexed citations

2.

Olsson, Bob, Ronald Lautner, Ulf Andréasson, et al.. (2016). CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. The Lancet Neurology. 15(7). 673–684. 1415 indexed citations breakdown →

3.

Skillbäck, Tobias, Bahman Farahmand, Christoffer Rosén, et al.. (2015). Cerebrospinal fluid tau and amyloid-β_1-42in patients with dementia. Brain. 138(9). 2716–2731. 166 indexed citations

4.

Rosén, Christoffer, Bahman Farahmand, Tobias Skillbäck, et al.. (2015). Benchmarking biomarker‐based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem. Alzheimer s & Dementia. 11(12). 1470–1479. 14 indexed citations

5.

Skillbäck, Tobias, Christoffer Rosén, Fredrik Asztély, et al.. (2014). Diagnostic Performance of Cerebrospinal Fluid Total Tau and Phosphorylated Tau in Creutzfeldt-Jakob Disease. JAMA Neurology. 71(4). 476–476. 146 indexed citations

6.

Rosén, Christoffer, Ulf Andréasson, José Luís Molinuevo, et al.. (2014). Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders Extra. 4(2). 297–304. 79 indexed citations

7.

Skillbäck, Tobias, Bahman Farahmand, Jonathan W. Bartlett, et al.. (2014). CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival. Neurology. 83(21). 1945–1953. 201 indexed citations

8.

Zetterberg, Henrik, Ronald Lautner, Tobias Skillbäck, et al.. (2014). CSF in Alzheimer's Disease. Advances in clinical chemistry. 65. 143–172. 17 indexed citations

9.

Rosén, Christoffer, Hans Rosén, Ulf Andréasson, et al.. (2013). Cerebrospinal fluid biomarkers in cardiac arrest survivors. Resuscitation. 85(2). 227–232. 20 indexed citations

10.

Rosén, Christoffer, Oskar Hansson, Kaj Blennow, & Henrik Zetterberg. (2013). Fluid biomarkers in Alzheimer’s disease – current concepts. Molecular Neurodegeneration. 8(1). 20–20. 166 indexed citations

11.

Rosén, Christoffer & Henrik Zetterberg. (2013). Cerebrospinal fluid biomarkers for pathological processes in Alzheimer's disease. Current Opinion in Psychiatry. 26(3). 276–282. 15 indexed citations

12.

Rosén, Christoffer, Ulf Andréasson, Niklas Mattsson, et al.. (2012). Cerebrospinal Fluid Profiles of Amyloid β-Related Biomarkers in Alzheimer’s Disease. NeuroMolecular Medicine. 14(1). 65–73. 55 indexed citations

13.

Rosén, Christoffer, Niklas Mattsson, Per Johansson, et al.. (2011). Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases. Frontiers in Aging Neuroscience. 3. 1–1. 58 indexed citations

14.

Veldt, Bart J., John J. Poterucha, K.D.S. Watt, et al.. (2009). Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C. American Journal of Transplantation. 9(6). 1406–1413. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact